Is there a need to redefine the diagnostic criteria for common variable immunodeficiency? - Wikidata - awgldk - TriplyDB

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

http://www.wikidata.org/entity/Q44772565

about

Comparison of diagnostic criteria for common variable immunodeficiency disorder Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.Immune deficiency in chronic rhinosinusitis: screening and treatment.Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.Evaluation of Known Defective Signaling-Associated Molecules in Patients Who Primarily Diagnosed as Common Variable Immunodeficiency.Application of diagnostic and treatment criteria for common variable immunodeficiency disorder.Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID).Common variable immunodeficiency (CVID): new genetic insight and unanswered questions.

P2860

Q26859119-FC22195D-5102-4B59-A933-03E39EC5C1D3 Q30245322-9A0D52B6-A958-4757-98FF-FA87504045B0 Q30248581-15C44521-ED16-40F5-A171-D04B5AE0C0CF Q38211700-FEA86291-7087-4BEC-8959-DD023CA3C6DC Q38767112-5FF93CEB-FC9A-4347-959B-E61A3CD8C5BF Q41084077-A4BCBAFC-2D8C-413D-9F77-6A9BC3A4428A Q49907965-0006CCC9-C566-4605-90FD-537703C4E84E Q54299709-81B43D0C-9C06-4410-8835-7F411AAFB1E6

P2860

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

http://www.wikidata.org/entity/Q44772565

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

@en

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

@nl

type

label

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

@en

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

@nl

prefLabel

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

@en

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

@nl

P1433

Q44772565-9B2A39A4-26E3-4D68-8AA1-EB8FC0C03DF1

P1476

Q44772565-1C63EE03-6F33-4881-A474-056A0A4F65C5

P2860

Q44772565-07A6CF42-7C1A-4869-AC81-54192C445805

Q44772565-10AE944E-CF57-4E2C-A35F-1B1DDD5C0586

Q44772565-128FA0C6-C19D-4D14-8818-CACF20805FC4

Q44772565-172117B5-3CB2-4DB2-A1FF-FA2F71DE20FD

Q44772565-288D3B5A-BAC7-44CB-8A92-1BC7361B6E30

Q44772565-4B4BA692-4E43-4C37-8C2A-0CE5DB5CCEC4

Q44772565-523E99A5-7F73-4E4F-BD30-EFC5BF53B1A1

Q44772565-55EDD7C3-D68D-4EEA-961E-8A83BE268A04

Q44772565-59781250-FD36-4005-9395-EF68F06921E2

Q44772565-60D334AE-7DAC-408E-B931-149CFE67465F

P304

Q44772565-278E853F-2723-49A4-BB20-A67C51C923A8

P31

Q44772565-79e0c789-f646-4249-af04-44d153fd734b

Q44772565-D3DE1182-2895-4830-A574-F308EE964FBE

P356

Q44772565-9F516339-D2CA-461B-9A85-34876D2AD942

P433

Q44772565-493D8245-7C93-4931-81D3-C53A6B21E592

P478

Q44772565-15D906B3-E975-4C5D-A823-1058AA0BA132

P50

Q44772565-786F99FE-09BF-46EE-9D51-71420D5ED6E3

Q44772565-BFC0D828-AB19-4537-B2F4-DCB272AE2EB6

Q44772565-DCF52981-C542-4360-B36B-72A53F232C0D

P577

Q44772565-115DFD6C-083F-4A3C-9EF0-7B6054660D07

P698

Q44772565-2F011D82-8C56-46A7-9AC3-C0B104FB685C

P356

1744666X.2014.870478

P1433

Expert Review of Clinical Immunology

P1476

Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?

@en

P2860

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.

Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency

Treatment of hypogammaglobulinemia in adults: a scoring system to guide decisions on immunoglobulin replacement.

Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency

Genome-wide association identifies diverse causes of common variable immunodeficiency

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study.

Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum

Key aspects for successful immunoglobulin therapy of primary immunodeficiencies.

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2014.870478

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Mikko Seppänen

Asghar Aghamohammadi

P577

2013-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24325452

http://www.w3.org/2001/XMLSchema#string